YN001-004 in Patients With Coronary Atherosclerosis in Australia

Summary

This study is to evaluate the efficacy and safety of intravenously administered YN001 in patients with coronary atherosclerosis in Australia. This study will be conducted in eligible participants with a diagnosis of coronary atherosclerosis, and at least 1 coronary artery is blocked determined by coronary computed tomography angiography (CCTA)

Timeline

Start

2026-02-25

Primary completion

2026-07-22

Completion

2026-07-22

Outcome

Outcome not reported

Stopped: “The study was terminated at the request of the Sponsor.”

Drugs

Indications